Plant ID: NPO4619
Plant Latin Name: Artemisia gilvescens
Taxonomy Genus: Artemisia
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
CA2; CA7; CA12; CA9; | |
GFER; HSD17B10; ALDH1A1; | |
CASP7; CASP1; |
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.930E-11 | 1.073E-06 | CA12, CA2, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.116E-09 | 2.304E-05 | CA12, CA2, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.868E-09 | 3.533E-05 | CA12, CA2, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.235E-07 | 2.626E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 1.083E-05 | 2.144E-02 | CA2, CA7 |
BP | GO:0050896; response to stimulus | GO:0014070; response to organic cyclic compound | 1.604E-05 | 2.910E-02 | CA2, CA9, CASP1, CASP7, CYP1A2 |
MF | GO:0003824; catalytic activity | GO:0097200; cysteine-type endopeptidase activity involved in execution phase of apoptosis | 1.876E-05 | 2.918E-02 | CASP1, CASP7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 7.476E-11 | 2.018E-09 | CA12, CA2, CA7, CA9 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 3.295E-04 | 4.133E-03 | CASP7, CASP1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 4.602E-04 | 4.133E-03 | CYP1A2, ALDH1A1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 6.124E-04 | 4.133E-03 | CASP7, CASP1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 3.020E-03 | 1.359E-02 | CASP7, HSD17B10 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.049E-02 | 4.914E-02 | CYP1A2, ALDH1A1, HSD17B10 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 1.342E-02 | 4.323E-02 | CA2 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 1.144E-02 | 4.323E-02 | CA2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.441E-02 | 4.323E-02 | CYP1A2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.498E-03 | 1.349E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |